IMCR vs JAZZ · rev $222.6M vs P/E 1988, rev $2.28B
Immunocore Holdings Ltd (IMCR) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Immunocore Holdings Ltd (IMCR) is a biotechnology company listed on NASDAQ.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported IMCR revenue for 2026-06-30 was $222.6M. Net income was $12.2M. IMCR currently screens at market cap $1.45B.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
IMCR currently screens at market cap $1.45B. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the IMCR and JAZZ stock pages for the full models.
Not investment advice.